Joint procurement of IOL-type medical consumables in Beijing, Tianjin and Hebei 9 provinces
At the end of April 2020, there was a joint procurement of IOL-type medical consumables in Beijing, Tianjin and Hebei 9 provinces.
22 May 2020 announced the joint procurement of the selected results notice shows that a total of 19 companies 44 products were selected, the average reduction of IOL is 53.72%, the highest reduction of 84.21%.
These involved Johnson & Johnson Visioncon, Nippon Nidec Corporation, Arion Technology Corporation, and Human Optics AG, among others.
As of October 2020, a total of 22 provinces nationwide have completed five rounds of IOL band purchasing, with price reductions ranging from 18% to 85%.
At present, several large inter-provincial alliances have been formed: the Beijing-Tianjin-Hebei "3+N" alliance, the Guangdong and other 16 provinces alliance, eight provinces and two regions, and the Sanming procurement alliance...
According to the collection trend, the coalition with volume procurement will continue to expand, the price will gradually achieve national linkage.

For the next set of procurement direction, the National Medical Security Bureau, deputy director Chen Jinfu said, will be normalized and institutionalized the amount of drugs and high-value medical supplies with procurement.
On the one hand, consolidate the new normal and promote the speed and expansion of collective procurement.
High-value medical consumables focus on orthopedic consumables, drug balloons, dental implants and other varieties, and strive to achieve an average of more than 350 drug varieties covered in each province and more than five varieties of high-value medical consumables through national organizations and provincial alliance procurement by the end of 2022, making it a new normal for pooling.
With regard to the collection of orthopedic consumables, drug balloons, dental implants and other consumable varieties, Chen Jinfu made it clear that this year, further extension to the spine consumables, so that orthopedic consumables basically reach the main coverage.
A mapping study of spinal consumables and standardization of information, including rules, is underway.
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharmapack Asia 2026 to Debut in Singapore, Connecting Pharma Packaging and Drug Delivery Leaders Across Asia-Pacific
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
Recommend Reading
-
Hormuz in Crisis: Freight Rates Surge to $6,000 as Global Trade Feels the Shock
-
Titanium Dioxide Prices Are Up Again! This Round of Increases Has One Real Driver: Sulfuric Acid
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Biologicals Move from Trial Plots to Real Distribution
-
Recent Continuous Decline in the Ethyl Acetate Market in China
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
Butadiene Rubber Market Prices Rise Sharply
-
Geopolitical Tensions Intensify, Causing a Significant Increase in Polyester Chip Prices
-
Chinese Ammonium Sulfate Market Prices Show Mixed Trends (4.13-4.23)